This protocol applies to paediatric patients — children younger than 16 years of age — presenting with epilepsy with myoclonic absences. Age is a defining factor in this clinical situation and directly informs antiepileptic drug selection and dosing strategy.
Management involves trialling an alternative antiepileptic monotherapy. Monotherapy with all indicated agents should be explored before initiating combination regimens. The specific drug, dosing guidance relative to any concurrent antiepileptic therapy, and the full decision algorithm are available in the complete protocol below.